Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
about
Prevention of hepatocellular carcinoma in patients with chronic hepatitis BTenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort.Tenofovir disoproxil fumarate: toxicity, toxicokinetics, and toxicogenomics analysis after 13 weeks of oral administration in miceThe frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.Efficacy of tenofovir disoproxil fumarate therapy in Chinese chronic hepatitis B patients after multiple antiviral failures.
P2860
Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
@en
type
label
Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
@en
prefLabel
Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
@en
P2860
P356
P1476
Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
@en
P2093
Maria Buti
Maria Homs
P2860
P304
P356
10.1586/EGH.12.19
P577
2012-08-01T00:00:00Z